If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -13.00 (-0.67%)
Bid:
1,914.00
Ask:
1,916.00
Spread: 2.00 (0.104%)
Market Cap: £3.22b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Change

9 Sep 2024 07:00

RNS Number : 3088D
Johnson Matthey PLC
09 September 2024
 

9th September 2024

 

Johnson Matthey Plc

(the Company)

Sinead Lynch to join Johnson Matthey as a Non-Executive Director

 

The Company is pleased to announce the appointment of Sinead Lynch as an independent Non-Executive Director with effect from 1st January 2025. Sinead will also become a member of the Remuneration, Nomination and Societal Value Committees.

 

Sinead brings a deep understanding of low carbon energy and sustainability, having spent 30 years in the energy sector at Royal Dutch Shell ("Shell") and BG Group ("BG"), including the last 10 years in an executive capacity. Most recently, she led Shell's Low Carbon Fuels business, developing technologies and investing in projects to produce sustainable renewable fuels at scale. Prior to this, Sinead was the UK Country Chair at Shell and led the Safety and Sustainability division of BG before its acquisition by Shell. She was also co-chair of the UK Hydrogen Advisory Council from 1st July 2020 until 1st August 2021.

 

Following a seven-year tenure, Jane Griffiths has taken the decision to step down as Chair of the Societal Value Committee and from the Board on 31st December 2024. Rita Forst will succeed Jane as Chair of the Societal Value Committee from 1st January 2025.

 

 

 

Patrick Thomas, Chair of Johnson Matthey said:

 

"On behalf of the Board, I would like to thank Jane for her significant contributions during her time with Johnson Matthey. In particular, her input and challenge to our sustainability commitments has been invaluable, and I wish her well for the future. I'm very pleased to welcome Sinead to the Board and look forward to benefiting from her expertise and advice, as JM continues to transform into an industry-leading energy transition company."

 

 

There are no further matters to be disclosed pursuant to UK Listing Rule 6.4.8R

 

 

ENDS

 

Enquiries: 

 

Simon Price

General Counsel and Company Secretary

+44 20 7269 8052

Martin Dunwoodie

Director of Investor Relations

+44 20 7269 8241

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGGLVVRGDZM
Date   Source Headline
10th Jan 20227:00 amRNSTransaction in Own Shares
7th Jan 202212:06 pmRNSDirector/PDMR Shareholding
7th Jan 20227:00 amRNSTransaction in Own Shares
6th Jan 202211:39 amRNSDirector/PDMR Shareholding
6th Jan 20227:00 amRNSTransaction in Own Shares
5th Jan 20225:21 pmRNSDirector/PDMR Shareholding
5th Jan 20227:00 amRNSTransaction in Own Shares
4th Jan 202211:45 amRNSDirector/PDMR Shareholding
4th Jan 20229:40 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSTransaction in Own Shares
31st Dec 20217:00 amRNSTransaction in Own Shares
30th Dec 20217:00 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20219:30 amRNSDirector/PDMR Shareholding
23rd Dec 20217:00 amRNSTransaction in Own Shares
22nd Dec 20214:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20217:00 amRNSTransaction in Own Shares - Replacement
21st Dec 20216:28 pmRNSTransaction in Own Shares
21st Dec 20214:15 pmRNSDirector/PDMR Shareholding
21st Dec 20211:47 pmRNSDirector/PDMR Shareholding
21st Dec 20217:00 amRNSShare buyback programme
20th Dec 20214:11 pmRNSDirector/PDMR Shareholding
17th Dec 20214:16 pmRNSHolding(s) in Company
17th Dec 20213:44 pmRNSDirector/PDMR Shareholding
17th Dec 20213:18 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSSale of Health
16th Dec 20212:20 pmRNSHolding(s) in Company
10th Dec 20214:40 pmRNSHolding(s) in Company
26th Nov 20215:15 pmRNSHolding(s) in Company
25th Nov 20214:30 pmRNSHolding(s) in Company
24th Nov 20217:00 amRNSJohnson Matthey half year results 30th Sept 2021
24th Nov 20217:00 amRNSSale of Advanced Glass Technologies
19th Nov 20213:30 pmRNSHolding(s) in Company
19th Nov 20212:02 pmRNSDirector/PDMR Shareholding
17th Nov 20219:47 amRNSHolding(s) in Company
11th Nov 20217:00 amRNSIntent to exit Battery Materials, trading update
11th Nov 20217:00 amRNSChief Executive Announcement
1st Nov 20218:30 amRNSJane Griffiths - External Directorship
22nd Oct 202110:13 amRNSDirector/PDMR Shareholding
12th Oct 202110:47 amRNSHolding(s) in Company
5th Oct 20218:00 amRNSJohn O'Higgins - External Directorship
28th Sep 202112:25 pmRNSHolding(s) in Company
20th Sep 20211:20 pmRNSHolding(s) in Company
16th Sep 202112:45 pmRNSDirector/PDMR Shareholding
25th Aug 20216:01 pmRNSHolding(s) in Company
20th Aug 20212:51 pmRNSDirector/PDMR Shareholding
18th Aug 20214:21 pmRNSDirector/PDMR Shareholding
18th Aug 20214:12 pmRNSDirector/PDMR Shareholding
12th Aug 202111:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.